Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, ...

Certain inhaler medications are used to treat asthma and contain the active drug fluticasone propionate. Xhance contains the same active drug, but it’s not approved to treat asthma. You may ...

Interventions: Patients entered a 4-week, open run-in period, receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was well controlled ...

Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).

Mylan has launched its generic version ... The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016.

Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...